Mounjaro usado en personas con obesidad Aquellas personas que tienen sobrepeso y obesidad sin diabetes pueden perder bastante peso con el uso de este frmaco y es que la tirzepatida reduce de media hasta el 22,5% (23,6 kg) del peso a la semana y, adems, 4 de cada 10 pacientes consiguieron una prdida igual o superior al 25%, cifras que solo da la ciruga baritrica
Tirzepatide has been studied in clinical trials for its role in supporting weight management and metabolic health
Some lean-mass reduction can occur during meaningful weight loss, but clinical trials consistently show that most weight lost is fat , not muscle
Prioritize Protein to Preserve Muscle One of the most important things to focus on, especially for anyone over 45, is preserving lean muscle
Metabolism Faster metabolism may clear the drug slightly quicker